BMET-37 PHASE I STUDY OF AZD3759, AN EGFR INHIBITOR WITH BLOOD BRAIN BARRIER (BBB) PENETRATION, FOR THE TREATMENT OF EGFRm+ NON-SMALL CELL LUNG CANCER (NSCLC) WITH BRAIN METASTASIS AND LEPTOMENGINGEAL METASTASIS

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Ahn, Myung-Ju, Kim, Dong-Wan, Martin, Paul, Davison, Chris, Yang, Zhenfan, Jiang, Haiyi, Yang, James Chih-Hsin
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638639/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov208.37
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars